Review papers by their claims

Executive summary

This paper reports a systematic yeast two‑hybrid (Y2H) mapping of Set1 and individual SET1C/COMPASS subunits (10 screens), followed by prioritized biochemical validation (GST/MBP pull‑downs, reconstituted SET1C from Sf9 cells, in vitro methylation assays, and MS mapping of PTMs). Major validated claims are: (1) extensive SET1C interactome linking it to RNA biogenesis, replication and chromatin remodeling; (2) SET1C SUMOylation at mapped Set1 lysines; (3) in vitro methylation of nonhistone proteins including Nrm1 (MBP fusion) and the Snf2 AT‑hook RG repeats; (4) in vivo Set1‑dependent arginine methylation of Snf2 ARTSTRGR residues by MS. Those findings, if reproduced broadly, expand COMPASS biological scope beyond nucleosomal H3K4 into nonhistone substrate methylation and regulatory cross‑talk between lysine and arginine modifications
All central claims and quantitative results derive from the paper's datasets and orthogonal validations; the Y2H resource (Table S2) and proteomics depositions are available for reanalysis SET1C Y2H and biochemical follow-up

Structure of this review

1. Major strengths and validated results
2. Critical methodological assessment and potential biases
3. Suggested follow‑ups and decisive experiments
4. Practical takeaways for chromatin and PTM researchers
5. Interactive resources and next steps

1) Major strengths and validated results

• Comprehensiveness of mapping — Ten independent Y2H screens (Set1 full length and two major fragments plus each subunit) create a broad interactome that recovers known SET1C biology (Spp1‑Mer2 meiotic link, Swd2‑CPF links) and uncovers many plausible new connections to RNA biogenesis, replication and remodeling proteins (Prp8, Prp22, Mcm2, Snf2) Y2H screen summary and interactome
• Orthogonal biochemical validation — authors did not stop at Y2H: they reconstituted SET1C in insect cells, performed pull‑downs, in vitro methylation with 3H‑SAM, and MS mapping to show arginine methylation of Snf2 AT‑hook and lysine methylation of Nrm1 (MBP fusion). These experiments substantially raise confidence that the interactions have biochemical meaning beyond Y2H detection Biochemical validation of Snf2 and Nrm1 methylation
• New credible biochemical claims — three specific, experimentally supported points stand out:
  1. Reconstituted SET1C can methylate multiple arginines in the ARTSTRGR motif of Snf2 AT‑hook in vitro; MS identified mono‑ and di‑methylation at R1490, R1501, R1505, R1507, R1517, etc. The same three positions (R1501 mono; R1505/R1507 di) are missing in set1Δ Snf2‑GFP purifications, consistent with Set1‑dependent methylation in vivo Snf2 AT-hook methylation mapping
  2. Nrm1 is methylated by SET1C in vitro when provided as an N‑terminal MBP fusion; Nrm1 contains an H3K4‑like motif (K118 aligning with H3 K4) suggesting H3K4‑like motifs can be nonhistone substrates — authors show MBP‑Nrm1, but not MBP alone, is methylated by partially purified SET1C (although histone is a more efficient substrate under the same conditions) Nrm1 in vitro methylation
  3. Set1 itself is SUMOylated at mapped lysines (evidence from 6His‑SUMO pulldowns and mutation mapping implicating K769 and an F5 region), a plausible regulatory mechanism for SET1C modularity (Spp1 association) Set1 SUMOylation mapping

2) Critical methodological assessment and potential biases

Overall the experimental pipeline is rigorous: Hybrigenics screens → selection by confidence scores → targeted biochemical orthogonal validations → MS‑based PTM mapping. That said, several methodological limitations must be stressed explicitly before adopting broader mechanistic claims.

2a Y2H limitations and interpretation

• Y2H detects binary interactions that can be bridged by endogenous yeast proteins or reflect interactions that occur in nonphysiological contexts (misfolding, overexpression of fragments) — the authors note this caveat and rightly prioritize biochemical follow‑up for key hits Y2H caveats acknowledged in paper
• Classic methodological note: Y2H false positive rate is non‑negligible; orthogonal validation (coIP, pull‑down, functional assay) is the essential filter (Fields and Song established the method and its caveats) Original Y2H method and caveats

2b In vitro methylation versus in vivo assignment

• Author's in vitro methylation of Snf2 AT‑hook by reconstituted SET1C is convincing (3H‑SAM autoradiography, MS mapping). However, attributing all in vivo methylation to direct SET1 catalytic activity requires caution: reconstituted complexes can co‑purify insect cell enzymes or enable nonphysiological promiscuous activity. The authors address this by showing Set1 deletion removes specific Snf2 arginine marks in yeast (strong orthogonal evidence) In vivo Set1 dependence for Snf2 methylation
• Mass spectrometry assignment of arginine mono/di methylation can be complicated by isobaric modifications and peptide coverage gaps; authors report inability to detect peptides that include the RG repeats directly from Snf2‑GFP, and infer some marks from flanking peptides — transparency in MS search space, spectra and PSM counts in the deposited data (PXD accessions) is crucial for community reanalysis.

2c PTM crosstalk and enzyme identity

The claim that SET1C directly methylates arginines is mechanistically striking because SET1 family enzymes are canonical lysine methyltransferases (SET domain). Authors present two alternate explanations: (A) SET1C directly catalyzes arginine methylation (novel enzymology), or (B) SET1C recruits/activates an arginine methyltransferase to the Snf2 site, and Set1 loss prevents that recruitment. The data (in vitro reconstituted SET1C methylates arginines on Snf2 fragments) lean toward (A) or at least to SET1C‑associated arginine methyltransferase activity, but a decisive biochemical experiment would be to reconstitute SET1C with catalytically dead Set1 (SET domain mutant) and test arginine methylation in vitro; authors partially address contaminant concerns but do not show a Set1 catalytic mutant eliminates Snf2 arginine methylation in the reconstituted system, which would distinguish direct vs cofactor explanations Set1C arginine methylation mechanistic ambiguity

3) Decisive follow‑up experiments I recommend (to falsify / confirm key mechanistic claims)

1. Reconstitute SET1C containing catalytic dead Set1 (point mutation in SET domain) in Sf9 and test in vitro methylation of Snf2 B3; loss of arginine methylation would support direct Set1 catalytic activity on arginine.
2. Purify recombinant yeast Set1 alone (or minimal SET domain) expressed in bacteria and test methyltransferase activity on Snf2 peptides and on H3 peptides to see if Set1 SET domain alone can generate arginine methylation, or if additional subunits are required.
3. Perform in vivo complementation: express catalytically inactive Set1 in set1Δ yeast and test restoration of Snf2 arginine methylation by MS; if inactive Set1 cannot restore the marks, that supports direct Set1 catalytic role.
4. Use selective PRMT inhibitors / PRMT deletion strains (rmt1/rmt2/hsl7 etc) combined with set1Δ to test genetic dependencies for Snf2 AT‑hook methylation: if combined PRMT deletions still show Set1 dependence, this supports novel SET1C‑linked activity rather than classic PRMTs (authors refer to prior coverage that Rmt1/Hmt1 may not be required for some R2 methylation events) Context on arginine methyltransferase redundancy

4) Data transparency, reproducibility and how well the paper supports its claims

• Reproducibility strengths: methods are detailed (Y2H by Hybrigenics, reconstituted SET1C in Sf9, MS acquisition on Orbitrap Fusion Lumos, MS search parameters) and mass spec datasets have been deposited to ProteomeXchange (PXD061448, PXD061496, PXD061531) so others can re‑analyse PTM site calls and PSMs — strong positive for reproducibility Data deposition and methods
• Reproducibility limitations: some critical MS peptides (RG repeat containing) were not directly recovered from Snf2‑GFP purifications (authors state they could not purify peptide containing the RG repeats), meaning some PTM calls rely on flanking peptide evidence and/or enriched in vitro preps; re‑analysis of raw spectra and targeted MS (PRM) would be valuable to confirm site localization unambiguously.

5) Practical takeaways and how to use the dataset

- Use Table S2 and the Hybrigenics overlap regions to design minimal interacting fragments if you want to reproduce or map interaction interfaces.
- Download ProteomeXchange PXD061496 and PXD061531 to reexamine Snf2‑GFP PTMs and PSM evidence (the authors deposited raw data). Reprocessing with different search settings (e.g., electron transfer for arginine methylation patterns, or using AspN digestion as they did for B3) can refine site localizations.
- If your lab studies COMPASS homologs in other organisms (e.g., MLL/SETD1 family in human), consider scanning orthologous remodelers for H3K4‑like motifs and RG repeats to evaluate conservation of nonhistone methylation events (authors propose H3K4‑like sequences as candidate nonhistone substrates). Search for H3K4-like motifs and candidate substrates

6) Bottom line appraisal

This is a high‑quality, resource‑rich study that combines systematic interactomics with rigorous biochemical follow‑up. Its most striking claims (nonhistone methylation and arginine methylation linked to Set1) are supported by multiple orthogonal data types, but do require the catalytic‑mutant and targeted MS follow‑ups suggested above to fully exclude alternative models. The dataset is likely to be valuable to the chromatin community and to researchers studying PTM cross‑talk.

7) Interactive resources and tools

- ProteomeXchange raw MS deposits: PXD061448 (Snf2‑B3), PXD061496 (Snf2‑GFP complex), PXD061531 (Snf2 PTMs) — reanalysis recommended.
- Use the Hybrigenics fragments (Table S2) to design targeted coIP/pulldown constructs.
- If you want BGPT to run iterative bioinformatics analyses (reprocess MS files, map interactors to orthologs, produce networks) click Run AI Biology Analysis below.

Author review links

(Author review pages — click to request bespoke author analyses):

Representative citations used in this review

• SET1C Y2H and biochemical follow-up
• Fields and Song Y2H method